Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the CytoSorbents First Quarter 2025 Earnings Conference Call. At this time, all lines are in listen-only mode.
Cytosorbents Corp (CTSO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Skylands Capital Charles Paquelet | 3,002,702 | $3,002,702 | +8% | 0.43% |
| 2. | Renaissance Technologies Jim Simons | 225,254 | $225,254 | +156% | 0% |
| 3. | Squarepoint Ops LLC Maxime Fortin (Cio) | 40,549 | $40,549 | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 8,183 | $8,183 | 0% | |
| 5. | 8,100 | $8,100 | -50% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.96 | 20,000 | $19,294.00 | 401,363 | 2024-12-13 | Filing | |
| $0.89 | 20,000 | $17,872.00 | 381,363 | 2024-12-12 | Filing | |
| $0.89 | 11,363 | $10,102.84 | 361,363 | 2024-12-11 | Filing | |
| $1.33 | 22,557 | $30,000.81 | 101,857 | 2023-12-13 | Filing | |
| $1.33 | 22,557 | $30,000.81 | 348,433 | 2023-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.40 | 4,000 | $37,591.20 | 125,046 | 2021-08-31 | Filing | |
| $8.00 | 8,000 | $64,000.00 | 125,046 | 2020-11-10 | Filing | |
| $10.00 | 10,000 | $100,000.00 | 417,649 | 2020-04-27 | Filing | |
| $6.00 | 4,677 | $28,062.00 | 417,649 | 2020-03-10 | Filing | |
| $9.37 | 24,337 | $228,025.52 | 503,281 | 2018-12-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,044,918 | $5,044,919 | 0.53% | |
| 2. | 1,949,551 | $1,949,551 | 0% | |
| 3. | 1,679,628 | $1,697,422 | 0% | |
| 4. | 954,076 | $954,076 | 0.96% | |
| 5. | 823,500 | $823,500 | 0.13% |
News See All
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentleman and welcome to the CytoSorbents' Corporation Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlight Conference Call.
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Catherine, and I will be your conference operator today.
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good afternoon, and welcome to the CytoSorbents Second Quarter 2024 Financial and Operating Results Conference Call.
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript
Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.11717, expectations were $-0.12.
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the CytoSorbents’ Fourth Quarter and Full-Year 2023 Financial and Operating Results Conference Call.
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to CytoSorbents third quarter 2023 financial and operating results conference call. [Operator Instructions].
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Cytosorbents First Quarter 2023 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Cytosorbents Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Is CTSO A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Billionaire Hedge Funds
